IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in IDEAYA Biosciences, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 285
- +33 vs. Q1 2026
- Shares held
- 102.2M
- +14.8M (+16.9%) vs. Q1 2026
- Total value
- $3.80B
- +$888.5M (+30.5%) vs. Q1 2026
- New holders
- 67
- 92 more added
- Sold out
- 34
- 88 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Evergreen Capital Management LLC | 0 | $0 | 0.00% | −11,439−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −10,869−100.0% | Sold out |
| Fieldview Capital Management, LLC | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −8,762−100.0% | Sold out |
| Contravisory Investment Management, Inc. | 0 | $0 | 0.00% | −8,183−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −8,150−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −6,832−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −6,363−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −3,010−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,880−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,563−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −1,338−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −960−100.0% | Sold out |
| Antipodes Partners Ltd | 0 | $0 | 0.00% | −917−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −251−100.0% | Sold out |
| Eastern Bank | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Golden State Equity Partners | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Vermillion Wealth Management, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |